Danish biotechnology company Bavarian Nordic said on Tuesday it had signed a $56 million contract with Canada for its smallpox vaccine, which is also approved for use against monkeypox in the country, with deliveries starting next year.
“In parallel, Bavarian Nordic continues to secure contracts with other countries, including Denmark, but also countries outside Europe, to supply the vaccine to mitigate the current monkeypox outbreak”, said the firm.
Bavarian will also host an investor call later on Tuesday at 1500 CET (1300 GMT).
ALSO READ FROM NIGERIAN TRIBUNE
THE Academic Staff Union of Universities (ASUU) has lauded the Federal Government for scrapping foreign…
• Says Brands must know their customers to enhance loyalty A marketing communications practitioner,…
NIGERIAN shipowners are currently in a state of confusion over possible mergers and collaboration following…
• 11 Discos received 203,116 complaints in H2, 2020 • Members spent N1.11trn on alternative…
The nation’s commercial banking, ride-hailing, and telecommunications sectors dominated the list of brands that demonstrated…
•We are ready, says CPC caucus •Plans to unveil party this month THERE are indications…
This website uses cookies.